Cellular Functions Of Programmed Cell Death 5.
Ge Li, D. Ma, Y. Chen
Published 2016 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Programmed cell death 5 (PDCD5) was originally identified as an apoptosis-accelerating protein that is widely expressed and has been well conserved during the process of evolution. PDCD5 has complex biological functions, including programmed cell death and immune regulation. It can accelerate apoptosis in different type of cells in response to different stimuli. During this process, PDCD5 rapidly translocates from the cytoplasm to the nucleus. PDCD5 regulates the activities of TIP60, HDAC3, MDM2 and TP53 transcription factors. These proteins form part of a signaling network that is disrupted in most, if not all, cancer cells. Recent evidence suggests that PDCD5 participates in immune regulation by promoting regulatory T cell function via the PDCD5-TIP60-FOXP3 pathway. The stability and expression of PDCD5 are finely regulated by other molecules, such as NF-κB p65, OTUD5, YAF2 and DNAJB1. PDCD5 is phosphorylated by CK2 at Ser119, which is required for nuclear translocation in response to genotoxic stress. In this review, we describe what is known about PDCD5 and its cellular functions.
This paper references
Cisplatin in combination with programmed cell death protein 5 increases antitumor activity in prostate cancer cells by promoting apoptosis.
Wenbin Zhu (2015)
Large-scale phosphorylation analysis of mouse liver
J. Villén (2007)
Studies on interactions of programmed cell death 5 (PDCD5) and its related peptides with heparin by capillary zone electrophoresis
Xiaomei Ling (2007)
Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response
Hyo-Kyoung Choi (2015)
PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis.
Lanjun Xu (2009)
Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression
Leonard Chen (2005)
YAF2 promotes TP53-mediated genotoxic stress response via stabilization of PDCD5.
Soo-yeon Park (2015)
SERUM PROGRAMMED CELL DEATH PROTEIN 5 (PDCD5) LEVELS IS UPREGULATED IN LIVER DISEASES
Yingyu Chen (2013)
PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells
Gui-ling Fan (2015)
Involvement of Autophagy in Cardiac Remodeling in Transgenic Mice with Cardiac Specific Over-Expression of Human Programmed Cell Death 5
L. An (2012)
TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal.
Hanxia Liu (1999)
hsp70-DnaJ chaperone pairs prevent nitric oxide-mediated apoptosis in RAW 264.7 macrophages
Tomoko Gotoh (2001)
Programmed Cell Death 5 Factor Enhances Triptolide-Induced Fibroblast-Like Synoviocyte Apoptosis of Rheumatoid Arthritis
Jun Jiang (2010)
Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress.
Soo-yeon Park (2015)
Programmed Cell Death Protein 5 Interacts with the Cytosolic Chaperonin Containing Tailless Complex Polypeptide 1 (CCT) to Regulate β-Tubulin Folding* ♦
Christopher M. Tracy (2013)
PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway
Lanjun Xu (2012)
The clinical significance of reduced programmed cell death 5 expression in human gastrointestinal stromal tumors.
F. Gao (2012)
Expression of programmed cell death 5 protein inhibits progression of lung carcinoma in vitro and in vivo via the mitochondrial apoptotic pathway.
Shining Xu (2014)
Down-regulation of programmed cell death 5 by insulin-like growth factor 1 in osteoarthritis chondrocytes
Chengqing Yi (2012)
A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome
U. Stelzl (2005)
Structure-function correlation of human programmed cell death 5 protein.
H. Yao (2009)
The involvement of programmed cell death 5 (PDCD5) in the regulation of apoptosis in cerebral ischemia/reperfusion injury.
C. Chen (2013)
Cellular Uptake of Exogenous Human PDCD5 Protein*
Ying Wang (2006)
Solution structure of S. cerevisiae PDCD5-like protein and its promoting role in H(2)O(2)-induced apoptosis in yeast.
Jingjun Hong (2009)
Retinal ganglion cell death is triggered by paraptosis via reactive oxygen species production: a brief literature review presenting a novel hypothesis in glaucoma pathology.
Yao Wang (2014)
Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation.
L. Farhana (2005)
The anti-tumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells.
Xiao-Rui Han (2012)
Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.
M. Salvi (2009)
Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo.
Anning Yin (2010)
Adenovirus-delivered PDCD5 counteracts adriamycin resistance of osteosarcoma cells through enhancing apoptosis and inhibiting Pgp.
Hui Zhao (2014)
c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis.
Y. Xia (2007)
Determination of binding constant and binding region of programmed cell death 5-heparin by capillary zone electrophoresis.
L. Yi (2007)
Proteomic analysis at the subcellular level for host targets against influenza A virus (H1N1).
Haibao Zhao (2013)
Effects of TFAR19 gene on the in vivo biorheological properties and pathogenicity of mouse erythroleukemia cell line MEL.
Gu Hua Li (2007)
Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells
Y. Yang (2006)
Multi-faceted role of HSP40 in cancer
Aparna Mitra (2009)
The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death
Florian J. Bock (2015)
Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo
Guo-Rui Ruan (2008)
Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells☆
Verena J. Haudek-Prinz (2012)
PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Juan Xiao (2013)
hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria
T. Gotoh (2004)
Expression and clinical significance of the programmed cell death 5 gene and protein in laryngeal squamous cell carcinoma
Fenglei Xu (2013)
Pretreatment of Mice with Oligonucleotide prop5 Protects Them from Influenza Virus Infections
Kang Li (2014)
Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells.
L. Shi (2010)
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis
Juan Xiao (2015)
Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.
Guanghui Han (2008)
A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions.
M. Lipinski (2010)
Low Programmed Cell Death 5 Expression is a Prognostic Factor in Ovarian Cancer
Li Gao (2015)
Expression of PDCD5, a novel apoptosis related protein, in human osteoarthritic cartilage.
Ai-xin Cheng (2004)
Tip60: Connecting chromatin to DNA damage signaling
Yingli Sun (2010)
NF-κB p65 recruited SHP regulates PDCD5-mediated apoptosis in cancer cells
Farhan Murshed (2013)
Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo
Changbao Chen (2010)
Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma.
Changbao Chen (2010)
PDCD5 protects against cardiac remodeling by regulating autophagy and apoptosis.
Shu Zhang (2015)
Human programmed cell death 5 protein has a helical-core and two dissociated structural regions.
Dongsheng Liu (2004)
Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis.
Yanhui Li (2013)
NMR studies of the interaction between human programmed cell death 5 and human p53.
H. Yao (2012)
PDCD5 expression predicts a favorable outcome in patients with hepatocellular carcinoma.
Da-Zhi Fu (2013)
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
M. Monte (2006)
Cleavage and Cytoplasmic Relocalization of Histone Deacetylase 3 Are Important for Apoptosis Progression
F. Escaffit (2006)
Plasma and synovial fluid programmed cell death 5 (PDCD5) levels are inversely associated with TNF-α and disease activity in patients with rheumatoid arthritis
Junfeng Wang (2013)
Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component
Miguel Torres-Martín (2013)
The N-terminal 26-residue fragment of human programmed cell death 5 protein can form a stable alpha-helix having unique electrostatic potential character.
Dongsheng Liu (2005)
Spindle Poisons and Cell Fate: A Tale of Two Pathways
Matson Dr (2011)
Regulation of p53 stability by Mdm2
M. Kubbutat (1997)
Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.
S. Tsuzuki (2007)
Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix
S. Sperandio (2004)
PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway
H. Li (2012)
Two Single-Nucleotide Polymorphisms with Linkage Disequilibrium in the Human Programmed Cell Death 5 Gene 5′ Regulatory Region Affect Promoter Activity and the Susceptibility of Chronic Myelogenous Leukemia in Chinese Population
X. Ma (2005)
Suppression of histone deacetylase 3 (HDAC3) enhances apoptosis induced by paclitaxel in human maxillary cancer cells in vitro and in vivo.
Norihiko Narita (2010)
Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritis
Ning Wang (2007)
Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation.
F. Yang (2006)
An alternative, nonapoptotic form of programmed cell death.
S. Sperandio (2000)
Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis?
Y. Chen (2001)
Cellular functions of TIP60.
Vasileia Sapountzi (2006)
Anti-Inflammatory Effects of Recombinant Human PDCD5 (rhPDCD5) in a Rat Collagen-Induced Model of Arthritis
Juan Xiao (2014)
Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris.
P. Zhang (2013)
Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
Guo-Rui Ruan (2006)
Association of the PDCD5 locus with lung cancer risk and prognosis in smokers.
M. Spinola (2006)
The von Hippel–Lindau tumor suppressor regulates programmed cell death 5-mediated degradation of Mdm2
Paul B M Essers (2014)
The 5'-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide.
M. Xu (2004)
Bax: Addressed to kill.
Thibaud T. Renault (2011)
An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression
Ying Wang (2004)
DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis.
Xiandan Cui (2015)
GSK3-TIP60-ULK1 Signaling Pathway Links Growth Factor Deprivation to Autophagy
Shu-Yong Lin (2012)
TCP1 complex is a molecular chaperone in tubulin biogenesis
M. Yaffe (1992)
Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals.
Kazushi Motomura (2004)
Programmed cell death 5 correlates with disease activity and interleukin-17 in serum and synovial fluid of rheumatoid arthritis patients.
Jun-Feng Wang (2013)
Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
H. Li (2008)
Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas.
Xiaoliang Zhang (2011)
Transfection of PDCD5 Effect on the Biological Behavior of Tumor Cells and Sensitized Gastric Cancer Cells to Cisplatin-Induced Apoptosis
Hui-Yu Xu (2012)
Autophagic effect of programmed cell death 5 (PDCD5) after focal cerebral ischemic reperfusion injury in rats
Zhao Jiang (2014)
This paper is referenced by
Programmed cell death 5 transgenic mice attenuates adjuvant induced arthritis by 2 modifying the T lymphocytes balance
Feng Yuan (2017)
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Shih-Yuan Peng (2018)
ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity
Lu Zhang (2017)
Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality
Ge Li (2017)
PDCD5 regulates cell proliferation, cell cycle progression and apoptosis.
Penghui Li (2018)
Programmed Cell Death 5 Provides Negative Feedback on Cardiac Hypertrophy Through the Stabilization of Sarco/Endoplasmic Reticulum Ca2+-ATPase 2a Protein
J. Ye (2018)
In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination
Javier Sotillo (2019)
The Molecular Evolution and Functional Divergence of Lamprey Programmed Cell Death Genes
X. Guan (2019)
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
M. Bouhaddou (2020)
Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
Zhili Ma (2019)
Genetics of eosinophilic esophagitis
Leah C. Kottyan (2017)
Effects of Yersinia ruckeri invasion on the proteome of the Chinook salmon cell line CHSE-214
S. Menanteau-Ledouble (2020)
β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance
Sha Jin (2019)
The reduced PDCD5 protein is correlated with the degree of tumor differentiation in endometrioid endometrial carcinoma
M. Gao (2016)
The Expression of TMEM74 in Liver Cancer and Lung Cancer Correlating With Survival Outcomes
Yizhe Sun (2018)
Crystal structure of the programmed cell death 5 protein from Sulfolobus solfataricus.
Kuan Fu Lin (2019)
PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision
Ke Wang (2018)
In-depth proteomic characterization of Schistosoma haematobium: towards the development of new tools for elimination
J. Sotillo (2018)
CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome
Yasser Perera (2020)